Navigation Links
U.S. Payers Intend to Limit Preferred Coverage to Only One Immune Biologic
Date:8/6/2009

NASHVILLE, Tenn. and GLEN ROCK, N.J., Aug. 6 /PRNewswire/ -- HealthLeaders-InterStudy and Fingertip Formulary find that 76 percent of surveyed pharmacy directors say that by 2014 they expect their managed care organization will have only one preferred biologic for all immune conditions, such as rheumatoid arthritis, psoriasis, Crohn's disease and ulcerative colitis. According to the new Formulary Forum report entitled Formulary Advantages in Immune Biologics: Tightening Payer Control Offers Opportunities for Differentiation, Centocor Ortho Biotech's Remicade and Abbott's Humira stand to most directly benefit from this strategy as these drugs are currently marketed and/or in development for multiple indications.

However, therapeutic area tenders, which are closed bids that pharmaceutical companies submit to payers that would give preferred access to patients at a set price, may present an opportunity for drug makers to compete with agents that are approved for multiple indications. More than half (58 percent) of surveyed pharmacy directors say they currently use therapeutic area tenders or are likely to adopt them within five years.

"While pharmacy directors are telling us they will offer preferred coverage to only one immune biologic, therapeutic area tenders may help some brands remain competitive with Remicade and Humira," said Michael Malecki, Ph.D., product manager for Formulary Forum. "For instance, UCB's Cimzia received U.S. approval for rheumatoid arthritis in May, so with this additional indication, UCB now has greater flexibility in being able to use tenders as a contracting strategy to get a stronger foothold in the marketplace."

The new Formulary Forum report is based on a survey of 50 pharmacy directors who control national, regional and state-level managed care organizations, as well as historical formulary data from Fingertip Formulary.

Webinar

Members of the media are welcome to attend our upcoming webinar entitled How Will My Brand Be Affected? An Examination of the Reimbursement and Prescribing of Immune Biologics and the Emergence of Novel Cost Control Measures. This webinar will be held on Thursday, August 13, 2009 at 12 p.m. U.S. Eastern Time. For more information, contact Lisa Osgood at 781-296-2606.

About Fingertip Formulary

Fingertip Formulary (www.FingertipFormulary.com), the leading provider of access to and insight into formulary data in the United States, offers comprehensive formulary data covering commercial, Medicaid, Medicare and PBM plans, among others. The company offers a variety of unique data and marketing solutions for the pharmaceutical industry, consultants and healthcare providers that provide access to and insight into formulary data. Fingertip Formulary is a Decision Resources, Inc. company.

About HealthLeaders-InterStudy

HealthLeaders-InterStudy, a Decision Resources, Inc. company, is the authoritative source for managed care data, analysis and news. For more information, please visit www.HL-ISY.com.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Both HealthLeaders-InterStudy and Fingertip Formulary are Decision Resources, Inc. companies. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.

    For more information, contact:

    Lisa Osgood                              Elizabeth Marshall
    HealthLeaders-InterStudy                 Decision Resources, Inc.
    781-296-2606                             781-296-2563
    losgood@hl-isy.com                       emarshall@dresources.com


'/>"/>
SOURCE HealthLeaders-InterStudy
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. District of Columbia Cigarette Tax Increase Delivers Victory for Kids and Taxpayers
2. Rising Medical Solutions, Inc. Launches Unified Healthcare Portal for Payers, Patients and Providers
3. Mississippi Tobacco Tax Increase is a Victory for Kids and Taxpayers
4. Hawaii Cigarette Tax Increase Delivers Victory for Kids and Taxpayers
5. Jopari Further Expands Nationwide Medical Billing Network Connectivity for Workers Comp and Auto Providers and Payers
6. Improved Care for Kidney Patients Reduces Medicare Costs and Saves Taxpayers Money
7. Rhode Island Cigarette Tax Increase Delivers Victory for Kids and Taxpayers; $1 Increase Gives State Highest Cigarette Tax in the Nation
8. The National Kidney Foundation of Florida Commends Senator Thad Altman, Representative Ritch Workman for Co-Sponsoring Common Sense Legislation Widely Hailed as Good for Patients, Good for Taxpayers, Good for Florida
9. IROs Help Cut Health Payers Costs and Improve Image
10. Independent Review Organizations Take Pressure Off Healthcare Payers as Recession Deepens
11. King Size Combo: New Report Reveals Broad Toll on Taxpayers by Bailed-Out Bank Goldman Sachs and Its Holdings in Burger King
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... ... February 22, 2017 , ... Doctors on Liens is continuing its ... Dr. Steven H. Rauchman, practicing at North Valley Eye Medical Group in Mission ... premise liability and other personal injury cases. These injuries have a major impact ...
(Date:2/22/2017)... ... February 22, 2017 , ... The ... today, as organizations, advocates, and individuals join together to increase recognition about the ... ultimately save lives. , “Today we mark a nationwide movement to raise awareness ...
(Date:2/22/2017)... ... February 22, 2017 , ... Bellus Medical, a leader in ... the delivery of Platelet Rich Plasma (PRP). PRP systems are used by physicians ... tissue synthesis and provide a faster and more efficient healing process. There are ...
(Date:2/22/2017)... ... February 22, 2017 , ... The SeniorCare Investor will ... Forecast —on Thursday, February 23, 2017, at 1:00 PM ET. A recording of the ... of the Interactive Webinar Series. , If you want to find out what really ...
(Date:2/22/2017)... ... February 22, 2017 , ... FPS is ... combat-related PTSD. , Established in 1977, our organization was at the forefront in ... returning to civilian life were evident and served as the catalyst for the ...
Breaking Medicine News(10 mins):
(Date:2/21/2017)... Patient Monitoring Equipment ... monitor physiological signs. These devices are either used as ... monitoring is one of the key factors for the ... market. Hence, vendors are developing technologically advanced products that ... send test results on time and provide better patient ...
(Date:2/21/2017)... Feb. 21, 2017 Micro Guide Catheters ... http://www.reportlinker.com/p04711314-summary/view-report.html Micro Guide Catheters ... hospitals, specialty clinics and ambulatory surgery centers etc. ... tip. The selection of micro guide catheter depends ... in human body. Micro guide catheters are available ...
(Date:2/21/2017)... IBM ) Research has today announced new research developments ... retina. The Melbourne based IBM researchers ... in retina images, which could in the future offer doctors ... who may be at risk of eye diseases – such ... world. The research began in 2015 and ...
Breaking Medicine Technology: